Dr Ateequllah Hayat is a lecturer in Drug Development on the Clinical Pharmacology BSc. He is the module lead for Year 1 and 2 Drug Development and contributes to teaching across the BSc including Year 3 Disease and Drug Targets A, Data and Statistics and Hot Topics. He also contributes to education and research on Biomedical Science BSc and Translational Medicine MRes.

Dr Ateequllah Hayat is an academic scientist with industry experience who obtained his PhD in Molecular Biology from Barts Cancer Institute, Queen Mary University of London. There he developed an in vitro breast cancer model to characterise signalling and epigenetic changes at the very onset of breast cancer progression. He then joined Imperial College London working with Myricx Pharma Limited, where he characterised compounds to target a post-translational modification in various cancers. Whilst molecular biologist by training, he is deeply interested in how drugs are developed with a passion for bioinformatics/genomics and analysis of next generation sequencing data.

Research interests: To understand genetic and epigenetic changes that drive cancer drug resistance and progression. To determine how these factors lead to changes at cellular level and phenotype changes that make cells resistant to targeted and chemotherapies. We do this by using next-generation sequencing techniques by profiling the transcriptional, epigenetic and proteomic approaches to elucidate the driving factors and identify key biomarkers and pathways to drive cancer drug discovery programme.

PhD students:

Ayesha Naeem

MRes students:

Jason Steggall (2023), Andisheh Niakan (2022)

Undergraduate students: 

Youssra Semlali (2023), Kahenat Kubari (2023), Naana Pokoo (2022), Preethhi Vanthiyathevan (2022)